MJardin Group, Inc., through its subsidiaries, operates as a specialized cannabis management company primarily in the United States and Canada. The company offers its partners turnkey cannabis cultivation, processing, and retail solutions, including licensure support, facility design, systems implementation, equipment leasing, and facility ramp-up services, as well as day-to-day personnel management and oversight, and operation services for large scale production facilities. It holds 36 cultivation, processing, and retail facilities under management. The company serves licensed cannabis cultivators, processors, and dispensaries. MJardin Group, Inc. was founded in 2014 and is headquartered in Denver, Colorado.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone720-613-4019
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
MJardin Group (OTCMKTS:MJARF) Frequently Asked Questions
What is MJardin Group's stock symbol?
MJardin Group trades on the OTCMKTS under the ticker symbol "MJARF."
What is the consensus analysts' recommendation for MJardin Group?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MJardin Group in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MJardin Group.
Has MJardin Group been receiving favorable news coverage?
Media headlines about MJARF stock have trended somewhat negative recently, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. MJardin Group earned a media sentiment score of -1.6 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for MJardin Group.
Who are some of MJardin Group's key competitors?
Some companies that are related to MJardin Group include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF).
What other stocks do shareholders of MJardin Group own?
Who are MJardin Group's key executives?
MJardin Group's management team includes the folowing people:
- Mr. Adrian T. Montgomery, Chairman & Interim CEO (Age 45)
- Chris Seto, Chief Financial Officer
- Mr. Jorge Boone, Chief Operating Officer
- Mr. Arthur J. Brown, Chief Accounting Officer (Age 70)
- Mr. Francis Knuettel II, Chief Strategy Officer (Age 53)
How do I buy shares of MJardin Group?
Shares of MJARF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is MJardin Group's stock price today?
One share of MJARF stock can currently be purchased for approximately $0.14.
What is MJardin Group's official website?
How can I contact MJardin Group?
The company can be reached via phone at 720-613-4019.
MarketBeat Community Rating for MJardin Group (OTCMKTS MJARF)
MarketBeat's community ratings are surveys of what our community members think about MJardin Group and other stocks. Vote "Outperform" if you believe MJARF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MJARF will underperform the S&P 500 over the long term. You may vote once every thirty days.
